Answer
It is licensed as first treatment for adults with locally advanced or metastatic non-small-cell lung cancer whose tumour has an activating EGFR mutation.
Sources for this answer
- Vizimpro 45 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.